This compound is primarily utilized in the field of biomedical research, particularly in targeted protein degradation studies. It serves as a key component in the development of PROTACs (Proteolysis Targeting Chimeras), which are designed to selectively degrade disease-causing proteins within cells. Its structure allows it to effectively bind to E3 ubiquitin ligase, facilitating the ubiquitination and subsequent degradation of specific target proteins. This application is crucial in exploring potential therapeutic strategies for various diseases, including cancer, neurodegenerative disorders, and viral infections. Additionally, it is employed in biochemical assays to study protein interactions and cellular pathways, aiding in the understanding of complex biological mechanisms.